Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.76 |
| ▸ | DPP8 | Q6V1X1 | 20/20 | 0.76 |
| ▸ | DPP7 | Q9UHL4 | 8/20 | 0.57 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3406474 | 1.00 | DPP4 (0.76) | DPP4DPP8DPP7DPP9 | |
| Trifluoroacetic Acid SCHEMBL2403603 | 0.87 | DPP4 (1.00) | DPP4DPP8DPP7 | |
| SCHEMBL8010909 | 0.85 | DPP4 (0.87) | DPP4DPP8DPP7DPP9 | |
| Trifluoroacetic Acid SCHEMBL2398411 | 0.84 | DPP4 (0.79) | DPP4DPP8DPP7 | |
| SCHEMBL2396924 | 0.83 | DPP4 (0.78) | DPP4DPP8DPP9 | |
| SCHEMBL3404667 | 0.83 | DPP4 (0.78) | DPP4DPP8DPP9 | |
| SCHEMBL8007572 | 0.82 | DPP4 (0.67) | DPP4DPP8DPP7DPP9 | |
| Trifluoroacetic Acid SCHEMBL2400454 | 0.79 | DPP4 (0.77) | DPP4DPP8DPP7 | |
| Trifluoroacetic Acid SCHEMBL3403495 | 0.79 | DPP4 (0.77) | DPP4DPP8DPP7 | |
| SCHEMBL7995578 | 0.77 | DPP4 (0.64) | DPP4DPP8DPP7DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8022096-B2 | Pyrrolidine derivatives | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2011-09-20 | — | — | US | disclosed |
| CN-101970402-A | Pyrrolidine compounds | NAT HEALTH RESEARCH INSTITUTES (TW) | 2011-02-09 | — | — | CN | disclosed |
| US-20090227569-A1 | PYRROLIDINE DERIVATIVES | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2009-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227569-A1 | PYRROLIDINE DERIVATIVES | DPP4, DPP7, DPP3 | DPP4 1/4885DPP8 4/4885DPP7 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.